Organization
Pancreatic Disease Center
1 abstract
Abstract
Perioperative fuzuloparib plus mFOLFIRINOX for resectable pancreatic adenocarcinoma: A phase 1 study.Org: Pancreatic Disease Center, Shanghai Jiao Tong University School of Medicine,
1 abstract